FDA Expanded Access Program (EAP)

Regulatory Framework

21 CFR 312.320

Eligibility Criteria

Patient has serious or life-threatening condition; no comparable/satisfactory alternative therapy; potential patient benefit justifies potential risks; patient enrollment in clinical trial not feasible; expanded access will not interfere with investigational trials

Available Drugs (0)

No drugs linked to this program.